Response

To the Editor:
We thank Dr Khurana for his thoughtful letter regarding our article on its implication in highly endemic countries with limited resources in culture and drug susceptibility tests. 1 The specifi city of positive sputum smear for acid-fast bacilli is highly affected by drug resistance status, especially in patients with multidrug resistant (MDR) TB, 2 who had a delayed culture conversion during treatment. Therefore, the assessment of treatment response should be different according to the status of drug resistance. Consistently, the results of our study 1 Since only 6% of TB cases in India were MDR TB, 3 our conclusion is applicable in probably . 70% of TB cases and should be helpful in saving medical resources. Early detection of drug resistance, especially rifampin resistance, is another important issue. Several risk factors have also been published to achieve early diagnosis of MDR TB, such as identifying patients with high pretreated probability of drug resistance (retreatment cases, poor response cases, MDR TB contacts, TB cases from highly prevalent areas of MDR TB) as well as early implementation of cost-effective rapid drug-resistance detection kits. 4 In addition, sputum mycobacterial culture and drug susceptibility testing should be performed to detect drug resistance if the specimen obtained at the end of 2 or 3 months is smear-positive. 5 Future large-scale investigations will be warranted to clarify the cost-effectiveness and priority of those strategies .
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